← Open Payments lookup

MANDY MCNAMARA: Open Payments

NPI 1376904136 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$505 in 23 payments from 12 companies in 2025. Trend: 2023 $805 · 2024 $636 · 2025 $505

Food & beverage: $505
CompanyPaymentsAmount
Novo Nordisk Inc6$132
PFIZER INC.2$52
ABBVIE INC.3$50
Astellas Pharma US Inc2$49
Merck Sharp & Dohme LLC2$49
Exact Sciences Corporation2$45
Lilly USA, LLC1$24
Esperion Therapeutics, Inc.1$23
Sumitomo Pharma America, Inc.1$22
Xeris Pharmaceuticals, Inc.1$20

Products named: Ozempic, PREVNAR 20, Veozah, CAPVAXIVE, The Cologuard Plus Collection Kit, Rybelsus, VRAYLAR, Wegovy.

Industry payments across MD — which companies pay providers there.